GSK CEO: AI could fix Big Pharma's R&D inefficiency
GlaxoSmithKline CEO Emma Walmsley says, "When we talk about health care costs, the single biggest thing we can do is innovate more.”
Source: fortune.com
Stay updated with breaking news from Will Daniel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GlaxoSmithKline CEO Emma Walmsley says, "When we talk about health care costs, the single biggest thing we can do is innovate more.”
The LinkedIn cofounder and Greylock partner says CEOs should use the tech to help workers adapt to the AI age.
48% of Fortune 500 CEOs agreed that ESG issues were "unduly impacting business decisions" as conservative politicians hammer ESG as ideologically driven.
The technology promises to be as revolutionary as the PC—but is daunting at first.
IBM's watsonx lets companies train custom A.I. without compromising data privacy.